Precision Medicine of Diabetes Program in China
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: no intervention.
- Who it may be relevant to
- Registry conditions: Diabetes. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The prevalence of diabetes has been increasing year by year. According to the International Diabetes Federation (IDF) statistics in 2021, the global number of people with diabetes has reached 537 million. The patient population is large and heterogeneous, and precise diagnosis and treatment of diabetes patients have been a focus of attention. The objective of this study is to clarify the current status of precision classification and diagnosis of diabetes patients through retrospective and prospective cohort studies, and to establish a model for precision classification and diagnosis of diabetes, improving the accuracy of diabetes classification and diagnosis; based on big data of precision medicine for diabetes patients and follow-up cohorts, to establish precise diagnostic, therapeutic, and predictive methods for diabetes; and through multi-omics data analysis, to explore the potential pathogenesis of diabetes, explaining the heterogeneity of patients, and guiding individualized treatment for patients.
Interventions
- Other no intervention
It's an observational study, no intervention included
Primary outcome measures
- The currency analysis of diabetes classification [Time frame: July 1st 2023 to December 31th 2023]
Secondary outcome measures (3)
- To establish a model for predicting diabetic retinopathy [Time frame: January 1st 2024 to December 31th 2028]
- To establish a model for predicting diabetic kidney disease [Time frame: January 1st 2024 to December 31th 2028]
- To establish a model for predicting diabetic neuropathy [Time frame: January 1st 2024 to December 31th 2028]
Eligibility criteria
Inclusion criteria
- Patients diagnosed with diabetes according to WHO 1999 criteria
Exclusion criteria
- with duration more than 1 year; Diabetes has not been diagnosed by WHO standards in 1999; Absence of medical history data
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- the Second Xiangya Hospital — Changsha
Identifiers
NCT: NCT06320600 · PDC